Lexicon Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US5288723027

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Alan J Main. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Alan J Main har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:LXRX / Lexicon Pharmaceuticals, Inc. EVP, Innov & Chem Sciences 339.104
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Alan J Main. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb LXRX / Lexicon Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i LXRX / Lexicon Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LXRX / Lexicon Pharmaceuticals, Inc. Insider Trades
Insidersalg LXRX / Lexicon Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i LXRX / Lexicon Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LXRX / Lexicon Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Alan J Main som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-03-03 2025-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -43.434 339.104 -11,35 0,67 -29.101 227.200
2025-03-03 2025-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 68.243 382.538 21,71
2025-03-03 2025-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 32.904 314.295 11,69
2025-03-03 2025-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25.667 281.391 10,04
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -24.408 255.724 -8,71 2,62 -63.949 669.997
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 32.903 280.132 13,31
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25.666 247.229 11,58
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8.977 221.563 4,22
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -20.946 212.586 -8,97 2,17 -45.453 461.312
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25.667 233.532 12,35
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8.976 207.865 4,51
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 23.300 198.889 13,27
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -8.977 17.953 -33,33
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -23.300 23.300 -50,00
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -22.373 0 -100,00
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -19.756 175.589 -10,11 2,85 -56.305 500.429
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8.977 195.345 4,82
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 23.300 186.368 14,29
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 22.373 163.068 15,90
2022-02-14 2022-02-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 77.000 77.000
2022-02-14 2022-02-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 230.990 230.990
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -23.300 46.600 -33,33
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -22.374 22.373 -50,00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -8.297 0 -100,00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.497 0 -100,00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -20.413 140.695 -12,67 7,19 -146.769 1.011.597
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 23.300 161.108 16,91
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 22.374 137.808 19,38
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8.297 115.434 7,74
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.497 107.137 2,39
2021-02-16 2021-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 80.780 80.780
2021-02-16 2021-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 26.930 26.930
2020-04-24 2020-04-22 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.813 104.640 -6,11 1,96 -13.353 205.094
2020-04-24 2020-04-22 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
A - Award 19.893 111.453 21,73
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -22.373 44.747 -33,33
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -8.296 8.297 -50,00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.498 2.497 -50,01
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -4.085 0 -100,00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -12.759 91.560 -12,23 2,77 -35.342 253.621
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 22.373 104.319 27,30
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8.296 81.946 11,26
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.498 73.650 3,51
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.085 71.152 6,09
2020-02-10 2020-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 209.700 209.700
2020-02-10 2020-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 69.900 69.900
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -8.297 16.593 -33,33
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.498 4.995 -33,34
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -4.085 4.085 -50,00
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -5.271 0 -100,00
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.885 67.067 -9,31 5,51 -37.936 369.539
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8.297 73.952 12,64
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.498 65.655 3,96
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.085 63.157 6,92
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.271 59.072 9,80
2019-02-08 2019-02-07 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 67.120 67.120
2019-02-08 2019-02-07 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 124.640 124.640
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.497 7.493 -24,99
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -4.085 8.170 -33,33
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -5.272 5.271 -50,00
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
M - Exercise -2.679 0 -100,00
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -4.962 53.801 -8,44 8,53 -42.326 458.923
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.497 58.763 4,44
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.085 56.266 7,83
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.272 52.181 11,24
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.679 46.909 6,06
2018-02-12 2018-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 69.940 69.940
2018-02-12 2018-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units
A - Award 24.890 24.890
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -4.085 12.255 -25,00
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -5.271 10.543 -33,33
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.678 2.679 -49,99
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.357 0 -100,00
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -5.361 44.230 -10,81 16,45 -88.188 727.584
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.085 49.591 8,98
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.271 45.506 13,10
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.678 40.235 7,13
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.357 37.557 6,70
2017-02-13 2017-02-09 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
A - Award 9.990 9.990
2017-02-13 2017-02-09 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 39.960 39.960
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -5.271 15.814 -25,00
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.679 5.357 -33,34
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.357 2.357 -50,00
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -2.500 0 -100,00
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -4.754 35.200 -11,90 9,07 -43.119 319.264
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.271 39.954 15,20
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.679 34.683 8,37
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.357 32.004 7,95
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.500 29.647 9,21
2016-02-16 2016-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
A - Award 16.340 16.340
2016-02-16 2016-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 65.340 65.340
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -18.750 56.250 -25,00
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -16.500 33.000 -33,33
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -17.500 17.500 -50,00
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
M - Exercise -16.250 0 -100,00
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -25.318 190.032 -11,76 0,94 -23.799 178.630
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 18.750 215.350 9,54
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 16.500 196.600 9,16
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 17.500 180.100 10,76
2015-03-03 2015-03-02 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 16.250 162.600 11,10
2015-02-09 2015-02-05 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 590.400 590.400
2015-02-09 2015-02-05 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock)
A - Award 147.600 147.600
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -16.500 49.500 -25,00
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -17.500 35.000 -33,33
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -16.250 16.250 -50,00
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
F - Taxes -18.668 146.350 -11,31 1,92 -35.843 280.992
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 16.500 165.018 11,11
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 17.500 148.518 13,36
2014-03-03 2014-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 16.250 131.018 14,16
2014-02-10 2014-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Stock Option (Right to Buy)
A - Award 300.000 300.000
2014-02-10 2014-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
A - Award 75.000 75.000
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -17.500 52.500 -25,00
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -16.250 32.500 -33,33
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
F - Taxes -12.572 114.768 -9,87 1,98 -24.893 227.241
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 17.500 127.340 15,93
2013-03-01 2013-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 16.250 109.840 17,36
2013-02-12 2013-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Stock Option (Right to Buy)
A - Award 264.000 264.000
2013-02-12 2013-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
A - Award 66.000 66.000
2013-02-04 2013-01-31 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -31.600 0 -100,00
2013-02-04 2013-01-31 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
F - Taxes -12.537 93.590 -11,81 2,11 -26.453 197.475
2013-02-04 2013-01-31 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 31.600 106.127 42,40
2012-03-01 2012-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
M - Exercise -16.250 48.750 -25,00
2012-03-01 2012-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
M - Exercise 16.250 74.527 27,88
2012-03-01 2012-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Common Stock
F - Taxes -5.907 58.277 -9,20 1,78 -10.514 103.733
2012-02-17 2012-02-15 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Stock Option (Right to Buy)
A - Award 280.000 280.000
2012-02-17 2012-02-15 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Restricted Stock Units (Phantom Stock)
A - Award 70.000 70.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)